Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-25T09:05:01.305Z Has data issue: false hasContentIssue false
  • English
  • Français

The Expectation of Outcome from Maintenance Therapy in Chronic Schizophrenic Patients

Published online by Cambridge University Press:  29 January 2018

D. A. W. Johnson
D. A. W. Johnson*
Affiliation:
Crumpsall Hospital, Manchester 8; and University of Manchester; University Hospital of South Manchester, West Didsbury, Manchester M20 8LR
Get access Rights & Permissions [Opens in a new window]

Summary

The results from a prospective follow-up study of a group of schizophrenic patients suggest that a significant proportion (41 per cent) are likely to relapse during a two-year period despite the prescription of long-acting injectable neuroleptic drugs. Some will relapse because of a failure of the regime, but others (32–37 per cent) because the pharmacological protection of these drugs would appear to be less effective in certain patients. Even with the major advantages of the long-acting injectable neuroleptics over oral medication, the schizophrenic patient population remains a group with a high incidence of psychiatric and social morbidity which continues to require the full resources of both the hospital and community services.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 128 , Issue 3 , March 1976 , pp. 246 - 250
Copyright
Copyright © Royal College of Psychiatrists, 1976 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carney, M. W. P. & Sheffield, B. F. (1973) The long-term maintenance treatment of schizophrenic outpatients with depot flupenthixol. Current Research and Opinion, 1, 423.Google Scholar
Denham, J. & Adamson, L. (1971) The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients. Acta Psychiatrica Scandinavica, 27, 420.CrossRefGoogle Scholar
Freeman, H. L. & Johnson, D. A. W. (1970) Community care. New Society, 15, 702.Google Scholar
Gottfries, C. G. (1971) Clinical trial of flupenthixol decanoate as a depot neuroleptic. Nordisk Psykiatrisk Tidsskirft, 25, 296.Google Scholar
Hirsch, S. R., Gaind, R., Rohde, P. D., Stevens, B. C. & Wing, J. K. (1973) Out-patient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. British Medical Journal, i, 633.Google Scholar
Imlah, N. W. & Murphy, K. P. (1970) Preliminary follow-up study of patients attending a Modecate clinic. Paper presented at Symposium on long-acting phenothiazines at the State University, Groningen, Holland. Published by E. R. Squibb Limited.Google Scholar
Johnson, D. A. W. (1973) The side-effects of fluphenazine decanoate. British Journal of Psychiatry, 123, 519.Google Scholar
Johnson, D. A. W. (1975) Observations on the dose regimes of fluphenazine decanoate in maintenance therapy of schizophrenia. British Journal of Psychiatry, 126, 457.Google Scholar
Johnson, D. A. W. & Freeman, H. L. (1972) The long-acting tranquillizers. The Practitioner, 208, 395.Google Scholar
Johnson, D. A. W. & Freeman, H. L. (1973) Drug defaulting by patients on long-acting phenothiazines. Psychological Medicine, 3, 115.CrossRefGoogle ScholarPubMed
Johnson, D. A. W. & Malik, N. A. (1975) A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia. Acta Psychiatrica Scandinavica, 51, 257.Google Scholar
Leff, J. P. (1973) Influence of selection of patients on results of clinical trials. British Medical Journal, iv, 156.Google Scholar
Leff, J. P. & Wing, J. K. (1971) Trial of maintenance therapy in schizophrenia. British Medical Journal, i, 559.Google Scholar
Mellor, C. S. (1970) First rank symptoms of schizophrenia. British Journal of Psychiatry, 117, 15.Google Scholar
Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale. Psychological Reports, Southern Universities Press, 10, 799.Google Scholar
Rasmussen, D. S. (1970) Fluphenazine enanthate in sesame oil, a depot preparation. Acta Psychiatrica Scandinavica, 46, 311.CrossRefGoogle ScholarPubMed
Stevens, B. C. (1973) Role of fluphenazine decanoate in lessening the burden of chronic schizophrenia on the community. Psychological Medicine, 3, 141.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.